European Bioanalysis Forum: recommendation on dealing with hemolyzed and hyperlipidemic matrices.

Recent guidelines on bioanalytical method validation have recommended to investigate matrix effects in special matrices such as hemolytic and hyperlipidemic plasma. However, these guidelines were not clear on how to implement these recommendations. The European Bioanalysis Forum has discussed this topic in depth and has asked for feedback from member companies. Those discussions have resulted in more specific guidance on how to define hemolytic and hyperlipidemic plasma, how to validate bioanalytical methods for these matrices and how to deal with hemolytic and hyperlipidemic study samples. These recommendations are presented in this manuscript.

[1]  J. Foley,et al.  Reduction in matrix-related signal suppression effects in electrospray ionization mass spectrometry using on-line two-dimensional liquid chromatography. , 2001, Analytical chemistry.

[2]  Fabio Garofolo,et al.  Bioanalytical Method Validation , 2004 .

[3]  Heather Myler,et al.  Large Molecule Specific Assay Operation: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team , 2013, The AAPS Journal.

[4]  B. Matuszewski,et al.  Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. , 1998, Analytical chemistry.

[5]  Binodh DeSilva,et al.  Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of Macromolecules , 2003, Pharmaceutical Research.

[6]  Fabio Garofolo,et al.  Impact of sample hemolysis on drug stability in regulated bioanalysis. , 2011, Bioanalysis.

[7]  S. Kazmierczak Hemolysis, Lipemia, and High Bilirubin: Effect on Laboratory Tests , 2013 .

[8]  W. Weinmann,et al.  Ion suppression effects in liquid chromatography-electrospray-ionisation transport-region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  Nora Nikolac,et al.  Lipemia: causes, interference mechanisms, detection and management , 2014, Biochemia medica.

[10]  Philip Timmerman,et al.  The European Bioanalysis Forum community's evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method Validation. , 2013, Bioanalysis.

[11]  Hemolysis of Blood Samples has no Significant Impact on the Results of Pharmacokinetic Data , 2012 .

[12]  R. Vries,et al.  Aging of biological matrices and its effect on bioanalytical method performance , 2013 .

[13]  M. I. Maguregui,et al.  Bioanalytical chromatographic method validation according to current regulations, with a special focus on the non-well defined parameters limit of quantification, robustness and matrix effect. , 2014, Journal of chromatography. A.

[14]  W. Price,et al.  Using calibration approaches to compensate for remaining matrix effects in quantitative liquid chromatography/electrospray ionization multistage mass spectrometric analysis of phytoestrogens in aqueous environmental samples. , 2007, Rapid communications in mass spectrometry : RCM.

[15]  Erin Chambers,et al.  Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  Milton Furtado,et al.  Severe impact of hemolysis on stability of phenolic compounds. , 2013, Bioanalysis.

[17]  W. Lambert,et al.  Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid , 2003, Journal of the American Society for Mass Spectrometry.

[18]  H Kenneth Walker,et al.  Clinical methods: The history, physical, and laboratory examinations , 1976 .

[19]  S. Gagné,et al.  Impact of hemolysis during sample collection: how different is drug concentration in hemolyzed plasma from that of normal plasma? , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  Nicola C Hughes,et al.  Assessing the matrix effects of hemolyzed samples in bioanalysis. , 2009, Bioanalysis.